118 related articles for article (PubMed ID: 36498937)
1. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.
Rouce RH; Shaim H; Sekine T; Weber G; Ballard B; Ku S; Barese C; Murali V; Wu MF; Liu H; Shpall EJ; Bollard CM; Rabin KR; Rezvani K
Leukemia; 2016 Apr; 30(4):800-11. PubMed ID: 26621337
[TBL] [Abstract][Full Text] [Related]
2. Nano-chemical priming strategy to enhance TGF-β resistance and anti-tumor activity of natural killer cells.
Choi SH; Cho HB; Choi JH; Kim HJ; Jang HJ; Cho S; Maeng E; Park H; Ryu KS; Park KH; Park KS
J Control Release; 2024 Mar; 367():768-778. PubMed ID: 38341178
[TBL] [Abstract][Full Text] [Related]
3. TGF-β signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer.
Wong JKM; McCulloch TR; Alim L; Omer N; Mehdi AM; Tuong ZK; Bonfim-Melo A; Chung E; Nicol A; Simpson F; Rhee H; Rossi GR; Souza-Fonseca-Guimaraes F
EBioMedicine; 2024 May; 104():105176. PubMed ID: 38810560
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Natural Killer Cell TGF-β and AhR Signaling Pathways Via the Intestinal Microbiota is Critical for Host Defense Against Alcohol-Associated Bacterial Pneumonia.
Samuelson D; Villageliu D; Cunningham K; Smith D; Knoell D; Mandolfo M; Wyatt T
Res Sq; 2023 Oct; ():. PubMed ID: 37886455
[TBL] [Abstract][Full Text] [Related]
5. Natural Killer Cell Dysfunction In Human Bladder Cancer Is Caused By Tissue-Specific Suppression of SLAMF6 Signaling.
Farkas AM; Tran MA; Youssef D; Balan S; Newman JH; Audenet F; Anastos H; Peros A; Ananthanarayanan A; Daza J; Gonzalez-Gugel E; Sadanala K; Theorell J; Galsky MD; Horowitz A; Sfakianos JP; Bhardwaj N
bioRxiv; 2024 May; ():. PubMed ID: 38746459
[TBL] [Abstract][Full Text] [Related]
6. Innatus immunis: Evolving paradigm of adaptive NK cells.
Khalil M; Malarkannan S
J Exp Med; 2022 Nov; 219(11):. PubMed ID: 36066493
[TBL] [Abstract][Full Text] [Related]
7. HPK1 Dysregulation-Associated NK Cell Dysfunction and Defective Expansion Promotes Metastatic Melanoma Progression.
Choi WS; Kwon HJ; Yi E; Lee H; Kim JM; Park HJ; Choi EJ; Choi ME; Sung YH; Won CH; Sung CO; Kim HS
Adv Sci (Weinh); 2024 Jun; ():e2400920. PubMed ID: 38828677
[TBL] [Abstract][Full Text] [Related]
8. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
[TBL] [Abstract][Full Text] [Related]
9. Preventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β Immunotherapeutics.
Market M; Tennakoon G; Scaffidi M; Cook DP; Angka L; Ng J; Tanese de Souza C; Kennedy MA; Vanderhyden BC; Auer RC
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498937
[TBL] [Abstract][Full Text] [Related]
10. A Method of Assessment of Human Natural Killer Cell Phenotype and Function in Whole Blood.
Market M; Tennakoon G; Ng J; Scaffidi M; de Souza CT; Kennedy MA; Auer RC
Front Immunol; 2020; 11():963. PubMed ID: 32508837
[TBL] [Abstract][Full Text] [Related]
11. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.
Lee JC; Lee KM; Kim DW; Heo DS
J Immunol; 2004 Jun; 172(12):7335-40. PubMed ID: 15187109
[TBL] [Abstract][Full Text] [Related]
12. Platelet-Derived Ectosomes Reduce NK Cell Function.
Sadallah S; Schmied L; Eken C; Charoudeh HN; Amicarella F; Schifferli JA
J Immunol; 2016 Sep; 197(5):1663-71. PubMed ID: 27448586
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
Guo SW; Du Y; Liu X
Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
[TBL] [Abstract][Full Text] [Related]
14. Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer.
Han B; Mao FY; Zhao YL; Lv YP; Teng YS; Duan M; Chen W; Cheng P; Wang TT; Liang ZY; Zhang JY; Liu YG; Guo G; Zou QM; Zhuang Y; Peng LS
J Immunol Res; 2018; 2018():6248590. PubMed ID: 30255106
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
